Altimmune director Wayne Pisano buys 10,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Altimmune, Inc. director Wayne Pisano purchased 10,000 shares of common stock directly on November 13, 2026, at $1.635 per share. His directly held position after the purchase was 58,800 shares. No Rule 10b5-1 plan was reported.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
1 txn
Insider
Pisano Wayne
Role
Director
Bought
10,000 shs ($16K)
Increase in Position
20.5%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 | 10,000 | $1.635 | $16K |
Holdings After Transaction:
Common Stock, par value $0.0001 — 58,800 shares (Direct)
Holdings Before and After:
Common Stock, par value $0.0001, 48,800 to 58,800 shares (Direct)
Other Insiders: 2 other insiders reported open-market purchases of this stock in the 30 days up to this filing.
Key Figures
Shares purchased: 10,000 shares
Purchase price: $1.635 per share
Direct shares following purchase: 58,800 shares
3 metrics
Shares purchased
10,000 shares
Direct purchase on November 13, 2026
Purchase price
$1.635 per share
Purchase on November 13, 2026
Direct shares following purchase
58,800 shares
Reported position after the purchase
Key Terms
Rule 10b5-1 plan
1 terms
Rule 10b5-1 plan regulatory
"No Rule 10b5-1 plan was reported"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.